Diabetes Flashcards
Indications for insulin use
- DM 1
- DM 2 → failure of oral drugs OR stress conditions (pregnancy, infection, surgery)
- DKA emergency IV regular insulin
- Hyperkalemia - insulin + IV glucose since insulin potassium shift into tissue
Treatment of insulin resistance
- Underlying cause - stress or infection
- Metformin - ↑ insulin sensitivity and ↓ intestinal glucose absorption
- Insulin sensitizers thiazolidinediones
- Change site of injection local insulin resistance
Adverse effects of insulin
- Hypoglycemia (most common and dangerous)
- Hypokalemia
- Insulin resistance
- Hypersensitivity reaction - urticaria, angioedema and anaphylactic shock
- Local effects
- Lipodystrophy - atrophy or hypertrophy
- Allergy at site of injection
- Local infection
Metabolic syndrome
Central obesity + hypercholesterolemia + heart disease + IR + DM 2
Insulin drug interactions
Hypoglycemia
Abs FM
1. Alcohol - ethanol inhibtis glucneogeneiss
2. Beta blockers - inhibit glycogensolysis and glucose release from liver and muscle + mask hypoglecmia
3. Salicylates
4. Fenfluramine - SSRI anorexic drugs ↑ serotonin in brain causing ↓ calorie intake + uptake of glucose into striated muscle
5. MAO - inhibit gluconeogenesis
Oral antidiabetic drugs
BTS ∝ M
1. Biguanides - metformin
2. Thiazolidinediones - pioglitazone and rosiglitazone
(pio and ros glitazone)
3. Sulfonylurea
4. ∝ glucosidase inhibitors- acarbose - miglitol
5. Meglitinides - repaglinide and nateglinide (me, repa, nate glinide)
Sulfonylurea
- amide - zide - ide
1st gen - amide
1. Chlorpropamide (long acting)
2. Tolbutamide
3. Acetohexamide
2nd gen -amide -zide
1. Glibenclamide
2. Glyclazide
3. Glipizide
3rd gen -ide
1. Glimepiride
CAT - amide
G
2nd gen - amide + zide
3rd gen - ide
30 minutes before breakfast
Mechanism of action of sulfonylureas
Pancreatic
1. ↑ insulin secretion - inhibits K+ ATP dependant channels
2. ↓ serum glucagon
Extrapancreatic
1. ↑ insulin receptor sensitivity
2. ↓ glucose hepatic output - gluconeogenesis
Adverse effect of sulfonylurea
- Hypoglycemia
- Chlorpropamide (long acting)
- Elderly patients with hepatic or renal dysfunction - Increased appetite and weight gain
- Pharmacological failure is common
- Primary 15-30%
- Secondary 6-7 yrs 90% - Hepatoxicity
- Allergic reactions
- Teratogenicity
Chlorpropamide - Disulfiram like reaction in patients that consume alcohol
- Dilutional hyponatremia SIADH
Sulfonylurea contraindications
- DM 1
- Renal, hepatic and liver failure
- Pregnancy “gestational diabetes” - fetal hypoglycemia
- Sulfa drug hypersensitivity - use meglitinide
Meglitinide
- glinide
1. Repaglinide
2. Nateglinide
Repa/nate glinide
- Just before meals to prevent postprandial hyperglycemia - very fast onset and short duration of action
- ORAL
Mechanism of action of Meglitinide
↑ insulin secretion - similar to sulfonylurea different binding site on beta cells
Adverse effects of meglitinide
Hypoglycemia
Contraindications
Use with caution in patients with renal and hepatic dysfunction
Biguanides
Metformin
- Oral x3 with meals
- Well absorbed from GIT
- Does not bind to plasma proteins
- Excreted unchanged
Mechanism of action of biguanides
Increases
1. Insulin receptor sensitivity
Decreases
2. Intestinal glucose absorption
3. Hepatic gluconeogenesis
DOES NOT CAUSE HYPOGLYCEMIA since it does not increase insulin secretion
Therapeutic uses of metformin (biguanides)
- DM 2 - alone if mild or combination
- Weigh loss (decreases glucose absorption)
- PCOS - decreases androgen levels + restores normal menstrual cycle and ovulation
Adverse effects of metformin (biguanides)
- GIT upset - anorexia, diarrhea and vomiting
- Lactic acidosis ↑ anaerobic glycolysis
- ↓ absorption of B12
Contraindications of metformin (biguanides)
Lactic acidosis
1. Patients with history of lactic acidosis
2. Renal or hepatic dysfunction
3. Chronic lung disease
Thiazolidinediones
- glitazone
1. Pioglitazone
2. Rosiglitazone
Slow onset + prolonged duration of action → gene regulation
Mechanism of action of thiazolidinediones (pioglitazone and rosiglitazone)
Nuclear gene PPAR γ (peroxisomal proliferator activated receptor gamma) in muscles, adipose tissue and liver
Increase
1. Insulin receptor sensitivity + ↓ insulin resistance
2. GLUT transporters ↑ glucose uptake
Decrease
3. TGs
DOES NOT CAUSE HYPOGLYCEMIA
Thiazolidinediones (pioglitazone and rosiglitazone) therapeutic use
Improve insulin resistance in DM 2
Adverse effects of thiazolidinediones (pioglitazone and rosiglitazone)
- Hepatoxicity
- Fluid retention - edema and weight gain (contraindicated in CHF)
Contraindications of thiazolidinediones (pioglitazone and rosiglitazone)
CHF